Chediak-Higashi Syndrome Treatment & Management: Approach Considerations, Medical Care, Surgical Care

In addition to appropriate antiemetic therapy, fluid resuscitation, and management of the patient’s symptoms, patients must recognize behaviors and exposures that place them at risk for their pathology. For supportive care, a clinician should work together with the pharmacist to see if any medications could contribute to the patient’s presentation. If administering antiemetics, the nursing staff should be familiar with the adverse event profile so they can report any concerns that marijuana addiction may arise. Chediak Higashi syndrome (CHS) is a rare autosomal recessive condition that was initially described by Beguez-Cesar in1943. Chediak in 1952 and Higashi in 1954 then discovered the maldistribution of myeloperoxidases in the granules of the neutrophils in affected patients.

Fig. 1.

Vici syndrome is characterized by a lack of pigment, immunodeficiency, lack of development of the corpus callosum, cataracts of both eyes, and cleft lip and palate. Cognitive impairment, seizures, and severe respiratory infections have also been observed with this syndrome. Oculocutaneous albinism is a disease that results in visual impairment and iris/retinal depigmentation. This can be diagnosed independent of CHS due to the lack of infectious history or neurologic abnormalities. The abnormal gene affects the “traffic patterns” or movement of proteins within the cells.

• Because CHS may present with neurologic dysfunction, it should be considered in the differential diagnosis of children and young adults first seen with symptoms of spinocerebellar degeneration or movement disorders.
• In contrast, NK cells from CHS patients with LYST BEACH domain mutations had more numerous granules, most of which appeared to be normal in size or slightly enlarged.
• If you’ve visited your PCP, met with specialists, and undergone the recommended tests, but still do not have a confirmed diagnosis, it may be time to visit a multidisciplinary care center.
• Characteristic clinical features and typical blood and bone marrow findings are essential for early diagnosis and treatment.
• To establish the extent of disease and needs in an individual diagnosed with Chediak-Higashi syndrome (CHS), the evaluations summarized in Table 4 (if not performed as part of the evaluation that led to the diagnosis) are recommended.

Cannabinoid Hyperemesis Syndrome FAQs

People with CHS also tend to have a strong urge to take very hot showers or baths. That’s because hot water can help ease cannabinoid hyperemesis syndrome symptoms like nausea. The hot temperature affects a part of the brain called chs symptoms the hypothalamus, which regulates temperature and throwing up.

• Several theories exist about the cause of this syndrome, including pesticides on marijuana plants, however most believe it is due to the increased potency of THC with advancements in the cultivation of the marijuana plant.
• If it is a patient’s first presentation for nausea, vomiting and abdominal pain, other primary etiologies such as gallbladder or intestinal disease, intoxications, or surgical emergencies should be considered, before a diagnosis of CHS is solidified.
• If an individual receives one normal gene and one abnormal gene for the disease, the person will be a carrier for the disease, but usually will not show symptoms.
• This LYST gene encodes the lysosomal trafficking regulator protein, which plays a crucial role in vesicular trafficking in cells across various tissues 7.

Catalog of Genes and Diseases from OMIM

Understanding of these mechanisms may provide further insight into the function of LYST. After stopping cannabis use, symptoms generally https://ecosoberhouse.com/ resolve within days or months. Research suggests that CHS is a permanent condition that can only be effectively treated by quitting cannabis.